Annual Drug Patent Expirations for QVAR+REDIHALER
Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are fourteen patents protecting this drug.
QVAR REDIHALER drug price trends.
Drug patent litigation for QVAR REDIHALER.
This drug has two hundred and thirty-eight patent family members in twenty-seven countries.
The generic ingredient in QVAR REDIHALER is beclomethasone dipropionate. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
